Kezdőlap・Részvénylista・Glaukos Corp

Glaukos Corp

Nyitva

SzektorEgészségügy

184.84 0.4

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

181.76

Maximum

185.18

Fő mutatók
By Trading Economics
Bevétel	1.4M -18M
Értékesítés	35M 186M
Egy részvényre jutó nyereség	-0.14
Profit margin	-9.901
Munkavállalók	1,094
EBITDA	-1.6M -6.9M

Ajánlások
By TipRanks
Ajánlások	Erős vétel
12 hónapos előrejelzés	+3.01% upside

Osztalékok
By Acuity
Következő eredményjelentés	2026. okt. 28.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	2B 11B
Előző nyitás	184.44
Előző zárás	184.84

Hangulat hírek alapján

By Acuity

40%

60%

117 / 340 Rangsor szerint Healthcare

Glaukos Corp Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 21. 19:56 UTC

Glaukos Corp's shares are higher today, reflecting a cumulative gain since Thursday. The stock remains near the upper end of its one-month range.

2026. aug. 20. 20:06 UTC

Glaukos Corp. shares are lower today, reflecting a decline from Wednesday's close. The stock earlier pulled back after reaching a session high.

2026. aug. 19. 20:06 UTC

News

Glaukos Corp will present at the Wells Fargo Healthcare Conference on September 9, 2026, as shares gain during Wednesday's trading session.

2026. aug. 14. 19:46 UTC

Glaukos Corp. shares are lower today, reaching a session low amid broader market declines following a surprise drop in U.S. retail sales for July.

2026. aug. 13. 19:22 UTC

Glaukos Corp. shares are higher today amid unusually high trading volume. The stock remains significantly above its 20-day moving average.

2026. aug. 12. 19:16 UTC

Glaukos Corp shares are higher today, supported by overall strength in U.S. stocks and positive quarterly results from AI sector companies.

2026. aug. 10. 20:06 UTC

Glaukos Corp shares are higher today, following a broader market trend since Friday. Earlier, the stock reached a session high before pulling back.

2026. aug. 7. 20:02 UTC

Glaukos Corp shares are rising in Friday's session, supported by unusually high trading volume and a steady upward trend since Thursday's close.

2026. aug. 4. 19:36 UTC

Glaukos Corp shares are lower today, impacted by declines in the Health Care Equipment sub-sector. The stock pulled back after reaching an earlier high.

2026. aug. 3. 20:06 UTC

Glaukos Corp shares are higher amid positive market sentiment, with the S&P 500 and Nasdaq 100 also gaining. The stock remains above its 20-day moving average.

2026. júl. 31. 19:45 UTC

News

Glaukos shares are lower today despite H.C. Wainwright raising the price target to $195 from $168. Trading volume has been unusually high.

2026. júl. 30. 21:31 UTC

News

Glaukos Corp shares are lower in after-market trading, tracking declines in the Health Care Equipment sector. UBS raised its price target to $172.

2026. júl. 29. 21:22 UTC

Social Media

News

Glaukos Corp reported record net sales of $185.6 million in Q2 2026, raising its full-year revenue guidance to $680 million to $700 million. Shares are higher in after-market trading.

2026. júl. 28. 17:46 UTC

News

Glaukos Corp shares are lower after UBS initiated coverage with a Neutral rating, overshadowing Stifel's Buy rating and $175 price target.

2026. júl. 27. 19:16 UTC

Glaukos Corp shares are lower today, despite an initial gain. Broader market trends are affected by a significant drop in oil prices.

2026. júl. 24. 19:56 UTC

Glaukos Corp. shares are trading higher today, maintaining a cumulative gain since Thursday and remaining above their 20-day moving average.

2026. júl. 21. 17:41 UTC

Glaukos Corp shares are lower today amid a decline in the Health Care Equipment sub-sector, reversing the recent trend of higher daily closes.

Társak összehasonlítása

Árváltozás

Glaukos Corp Előrejelzés

Célár

By TipRanks

3.01% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 190.46 USD 3.01%

Magas 225 USD

Alacsony 153 USD

14 Wall Street elemző 12 hónapos célárain alapulva a(z)Glaukos Corp termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

14 ratings

Vétel

Tartás

Eladás

14 Wall Street elemző célárain alapulva a(z)Glaukos Corp termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

117 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.